CytoDyn, Inc. (CYDY)
0.273
-0.01
(-2.35%)
USD |
OTCM |
Jun 17, 16:00
CytoDyn 1 Year Total Returns (Daily) : -19.85% for June 17, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 17, 2026 | -19.85% |
| June 16, 2026 | -20.12% |
| June 15, 2026 | -19.41% |
| June 12, 2026 | -19.83% |
| June 11, 2026 | -16.91% |
| June 10, 2026 | -18.10% |
| June 09, 2026 | -15.04% |
| June 08, 2026 | -14.66% |
| June 05, 2026 | -14.38% |
| June 04, 2026 | -15.14% |
| June 03, 2026 | -20.17% |
| June 02, 2026 | -15.86% |
| June 01, 2026 | -12.97% |
| May 29, 2026 | -12.94% |
| May 28, 2026 | -11.04% |
| May 27, 2026 | -1.63% |
| May 26, 2026 | -0.94% |
| May 22, 2026 | -0.29% |
| May 21, 2026 | -2.95% |
| May 20, 2026 | -10.22% |
| May 19, 2026 | -10.41% |
| May 18, 2026 | -9.49% |
| May 15, 2026 | -14.74% |
| May 14, 2026 | -17.54% |
| May 13, 2026 | -13.17% |
| Date | Value |
|---|---|
| May 12, 2026 | -8.82% |
| May 11, 2026 | -19.80% |
| May 08, 2026 | -1.49% |
| May 07, 2026 | -3.76% |
| May 06, 2026 | -17.43% |
| May 05, 2026 | -22.58% |
| May 04, 2026 | -6.16% |
| May 01, 2026 | 4.03% |
| April 30, 2026 | 15.75% |
| April 29, 2026 | 21.14% |
| April 28, 2026 | 31.29% |
| April 27, 2026 | 38.49% |
| April 24, 2026 | 29.72% |
| April 23, 2026 | 23.74% |
| April 22, 2026 | 58.93% |
| April 21, 2026 | 65.12% |
| April 20, 2026 | 75.49% |
| April 17, 2026 | 82.35% |
| April 16, 2026 | 83.33% |
| April 15, 2026 | 60.76% |
| April 14, 2026 | 61.79% |
| April 13, 2026 | 58.52% |
| April 10, 2026 | 35.44% |
| April 09, 2026 | 26.46% |
| April 08, 2026 | 30.58% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -5.26% |
| Alnylam Pharmaceuticals, Inc. | -8.42% |
| Savara, Inc. | 163.7% |
| Vericel Corp. | -5.71% |
| Biogen, Inc. | 56.98% |